Serialisation: Top Tech Integration Considerations

Add bookmark


We respect your privacy, by clicking "Download Your Copy" you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.

 Roger Bate from the American Enterprise Institute estimates that global economy is hit by $10 billion in losses due to counterfeit and substandard medicines alone. Life loss, he estimates, equates to around 100,000 deaths a year – primarily felt by emerging markets. 

These two costs are part of what sparked the introduction of serialisation – the method of tracing the lifecycle of the medicine via a serial number.
 
[inlinead] 
 
Undoubtedly, technology stands as a keystone in a controlled pharmaceutical track and trace system Like us at Facebook 

Therefore, it’s imperative for pharma and biotech firms to invest time and money in the right technology, the right partners and then focus on the integration and harmonisation of the serialisation process from a departmental and technological perspective. This integration is required across warehouse systems, shipping systems and packaging systems on an international basis – with some country specific regulations still pending.

 

Have Your Say
Rate this feature and give us your feedback in the comments section below

RECOMMENDED